Company news

Veritas In Silico Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Monthly Status of Exercise of #5 (with Exercise Price Adjustment Clause) and #6 to #9 Share Acquisition Rights(with Target Issue and Adjustment Optio

November 2, 2026

Syntara and Veritas In Silico sign MoU to Accelerate Joint Discovery Research for mRNA-Targeted Compounds

November 2, 2026

Notice of Completion of Payment for #5 and #6 to #9 Share Acquisition Rights by Third-Party Allotment

October 28, 2026

Notice Concerning Achievement of Research Milestone under Joint Drug Discovery with Toray Industries, Inc.

October 19, 2026

Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Under Japanese GAAP]

August 5, 2026

Joint Patent Application Filed for lncRNA-Targeting Drugs

August 2, 2026

Personnel Changes in Executive Officer

July 13, 2026

TABLE-Veritas In Silico -2025 parent results

February 11, 2026

TABLE-Veritas In Silico - 9-MTH parent results

November 11, 2025

TABLE-Veritas In Silico -2025 parent forecast

October 14, 2025

Decks

The 5 newest of 15 decks. Every deck is listed under its year.